跳至主要内容
临床试验/NCT01517997
NCT01517997已完成2 期

Infrapopliteal Drug Eluting Angioplasty Versus Stenting for the Treatment of Long-segment Arterial Disease: The IDEAS-I Randomized Controlled Trial.

University of Patras2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2011年8月最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
50
试验地点
2
主要终点
Angiographic Binary Restenosis

研究概览

简要总结

In total 50 patients diagnosed with long-segment infrapopliteal arterial disease will be randomized in two groups. The patients randomized in the Drug coated balloons (DCB) study arm will undergo a percutaneous transluminal angioplasty (PTA) with the use of a paclitaxel-coated balloon, while the patients randomized in the drug-eluting stent (DES) study arm will undergo primary stenting using drug-eluting stent(s). The study's primary endpoints will be the 6-month angiographic binary restenosis rate. Secondary endpoints will include the immediate technical success,6-month primary patency, target lesion revascularization and limb salvage and complication rates.

详细描述

Patients programmed to undergo PTA due to angiographically-proven infrapopliteal arterial disease in our department will be randomized in the above mentioned study arms. The studies primary endpoint will be assessed with the use of intra-arterial digital subtracted angiography and subsequent Quantitative Vascular Analysis (QVA) analysis.Clinical follow-up is set at 1, 3 and 6 months. Patients' baseline demographics and procedural details will be recorded and analyzed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Angiographically documented infrapopliteal disease.
  • Rutherford category of peripheral arterial disease between class 3 to 6
  • Lesion length between 70 to 220 mm
  • Lesions situated in the proximal, mid and mid to distal segments of the tibial vessels.

排除标准

  • Lesion length < 70 mm or > 220 mm.
  • Lesions situated in the distal third of the tibial vessels

研究组 & 干预措施

Drug Coated Balloon (DCB) Arm

Experimental

Patients included in this arm will undergo PTA with the use of a paclitaxel coated balloon.

干预措施: Paclitaxel coated balloon angioplasty. (Procedure)

Drug Eluting Stents (DES) Arm

Active Comparator

Patients in this arm will undergo primary infrapopliteal stenting of the target lesion using a drug-eluting stent.

干预措施: Infrapopliteal Primary Drug Eluting Stenting (Procedure)

结局指标

主要结局

Angiographic Binary Restenosis

时间窗: 6 months

Angiographic binary restenosis of the target lesion defined by quantitative vessel analysis at 6 months follow-up

次要结局

  • Procedure related complication rates(up to 30 days)
  • Limb salvage(6 months)
  • Technical success rate(intra-procedural)
  • Angiographic Primary Patency(6 months)
  • Target lesion revascularization(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

SIABLIS DIMITRIOS

Professor of RAdiology

University of Patras

研究点 (2)

Loading locations...

相似试验